Literature DB >> 9787000

Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function.

D A Simone1, M Nolano, T Johnson, G Wendelschafer-Crabb, W R Kennedy.   

Abstract

The ability of capsaicin to excite and subsequently to desensitize a select group of small sensory neurons has made it a useful tool to study their function. For this reason, application of capsaicin to the skin has been used for a variety of painful syndromes. We examined whether intradermal injection of capsaicin produced morphological changes in cutaneous nerve fibers that would account for its analgesic properties by comparing cutaneous innervation in capsaicin-treated skin with psychophysical measures of sensation. At various times after capsaicin injection, nerve fibers were visualized immunohistochemically in skin biopsies and were quantified. In normal skin the epidermis is heavily innervated by nerve fibers immunoreactive for protein gene product (PGP) 9.5, whereas fibers immunoreactive for substance P (SP) and calcitonin gene-related peptide (CGRP) are typically associated with blood vessels. There was nearly complete degeneration of epidermal nerve fibers and the subepidermal neural plexus in capsaicin-treated skin, as indicated by the loss of immunoreactivity for PGP 9.5 and CGRP. The effect of capsaicin on dermal nerve fibers immunoreactive for SP was less obvious. Capsaicin decreased sensitivity to pain produced by sharp mechanical stimuli and nearly eliminated heat-evoked pain within the injected area. Limited reinnervation of the epidermis and partial return of sensation occurred 3 weeks after treatment; reinnervation of the epidermis was approximately 25% of normal, and sensation improved to 50-75% of normal. These data show that sensory dysfunction after capsaicin application to the skin results from rapid degeneration of intracutaneous nerve fibers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787000      PMCID: PMC6793545     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin.

Authors:  R H LaMotte; L E Lundberg; H E Torebjörk
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

2.  The epidermal nerve fibre network: characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variations.

Authors:  D M Reilly; D Ferdinando; C Johnston; C Shaw; K D Buchanan; M R Green
Journal:  Br J Dermatol       Date:  1997-08       Impact factor: 9.302

Review 3.  Peppers and pain. The promise of capsaicin.

Authors:  B M Fusco; M Giacovazzo
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

4.  The consequences of long-term topical capsaicin application in the rat.

Authors:  Stephen B McMahon; Gary Lewin; Stephen R Bloom
Journal:  Pain       Date:  1991-03       Impact factor: 6.961

5.  Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation.

Authors:  A Saria; C R Martling; Z Yan; E Theodorsson-Norheim; R Gamse; J M Lundberg
Journal:  Am Rev Respir Dis       Date:  1988-06

Review 6.  The neuropharmacology of capsaicin: review of some recent observations.

Authors:  S H Buck; T F Burks
Journal:  Pharmacol Rev       Date:  1986-09       Impact factor: 25.468

Review 7.  Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides.

Authors:  P Holzer
Journal:  Neuroscience       Date:  1988-03       Impact factor: 3.590

8.  Capsaicin causes prolonged inhibition of voltage-activated calcium currents in adult rat dorsal root ganglion neurons in culture.

Authors:  R J Docherty; B Robertson; S Bevan
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

9.  Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture.

Authors:  J N Wood; J Winter; I F James; H P Rang; J Yeats; S Bevan
Journal:  J Neurosci       Date:  1988-09       Impact factor: 6.167

10.  Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia.

Authors:  T K Baumann; D A Simone; C N Shain; R H LaMotte
Journal:  J Neurophysiol       Date:  1991-07       Impact factor: 2.714

View more
  85 in total

Review 1.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

Review 2.  Transient receptor potential channels in pain and inflammation: therapeutic opportunities.

Authors:  Mark A Schumacher
Journal:  Pain Pract       Date:  2010-03-02       Impact factor: 3.183

Review 3.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

Review 4.  Exercise as Therapy for Diabetic and Prediabetic Neuropathy.

Authors:  J Robinson Singleton; A Gordon Smith; Robin L Marcus
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

5.  [Molecular basis for pain mediating properties of extracorporeal shock waves].

Authors:  J Hausdorf; C Schmitz; B Averbeck; M Maier
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

Review 6.  Without nerves, immunology remains incomplete -in vivo veritas.

Authors:  Andrew J Shepherd; James E G Downing; Jaleel A Miyan
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

Review 7.  [Interactions between itch and pain].

Authors:  M Schmelz
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

8.  Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells.

Authors:  Chiang Siau; Wenhua Xiao; Gary J Bennett
Journal:  Exp Neurol       Date:  2006-06-22       Impact factor: 5.330

Review 9.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

10.  Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief.

Authors:  G Jancsó; M Dux; O Oszlács; P Sántha
Journal:  Br J Pharmacol       Date:  2008-11-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.